Does CARFILZOMIB Cause Extravasation? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Extravasation have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.1% of all adverse event reports for CARFILZOMIB.
24
Reports of Extravasation with CARFILZOMIB
0.1%
of all CARFILZOMIB reports
0
Deaths
7
Hospitalizations
How Dangerous Is Extravasation From CARFILZOMIB?
Of the 24 reports, 7 (29.2%) required hospitalization.
Is Extravasation Listed in the Official Label?
Yes, Extravasation is listed as a known adverse reaction in the official FDA drug label for CARFILZOMIB.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Extravasation?
IRON SUCROSE (122)
FERRIC CARBOXYMALTOSE (103)
DOXORUBICIN (92)
FLUOROURACIL (90)
OXALIPLATIN (90)
IOHEXOL (89)
RITUXIMAB (77)
CYCLOPHOSPHAMIDE (65)
NIVOLUMAB (55)
INFLIXIMAB (53)
Which CARFILZOMIB Alternatives Have Lower Extravasation Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL